About
Lb Pharmaceuticals Inc — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
LB Pharmaceuticals Announces Publication in JAMA Psychiatry of Results from Phase 2 NOVA-1 Trial of LB-102 in Schizophrenia
Apr 9 2026
LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare Conference
Mar 27 2026
LB Pharmaceuticals Presents New Analysis from the Phase 2 NOVA-1 Trial Highlighting LB-102’s Potential Impact on Cognitive Performance at the 2026 Annual Congress of the Schizophrenia International Research Society (SIRS)
Mar 26 2026
LB Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Mar 25 2026
LB Pharmaceuticals Initiates Pivotal Phase 3 Trial (NOVA-2) for LB-102 in Patients with Schizophrenia
Recent Videos

From Legal to Leadership: Becoming a Successful Biotech CEO with Heather Turner
May 04, 2026

How to Invest in LB Pharmaceuticals Inc (LBRX) Step by Step
Apr 05, 2026

Lb Pharmaceuticals Inc 2025 annual report
Mar 27, 2026

Cómo comprar acciones de LB Pharmaceuticals Inc (LBRX)
Mar 22, 2026
Google Übersetzer